• Northisle Copper and Gold (NCX) has successfully raised gross proceeds of $2,002,935 from a non-brokered private placement of 12,139,000 common shares
  • Proceeds from the offering will be used primarily to fund development and exploration expenditures at the North Island Copper-Gold Project in B.C.
  • Northisle Copper and Gold Inc. is a Vancouver-based mineral resource company
  • Northisle Copper & Gold Inc. (NCX) is up 5.88 per cent on the day, trading at C$0.18 per share at 3 pm ET.

Northisle Copper and Gold (NCX) has successfully raised gross proceeds of $2,002,935 from a non-brokered private placement of 12,139,000 common shares.

The gross proceeds from the offering will be used primarily to fund development and exploration expenditures at the North Island Copper-Gold Project.

The North Island Project is located near Port Hardy, British Columbia.

Three of the company’s cornerstone investors, Donald K. Johnson, Michael Gentile, and Dale Corman, have participated in the offering, with Donald K. Johnson increasing his position to approximately 9.97 per cent, while Michael Gentile maintained his approximate 9.98 per cent stake and Dale Corman increased his position to 11.64 per cent.

Company President and CEO Sam Lee also participated in the offering.

All securities issued will be subject to a statutory four-month hold period.

About Northisle

Northisle Copper and Gold is a Vancouver-based mineral resource company. Northisle owns the North Island Project, one of the most promising copper and gold porphyry deposits in Canada. 

Northisle Copper and Gold Inc. (NCX) is up 5.88 per cent on the day, trading at C$0.18 per share at 3 pm ET.


More From The Market Online

ESE producing championship e-sports tournament for Riot Games

ESE Entertainment’s (TSXV:ESE) media production unit, Frenzy, takes on the distribution of the upcoming Teamfight Tactics e-sports tournament.

York Harbour Metals reveals more promising rare earth sampling assays

York Harbour Metals (TSXV:YORK) reports encouraging findings in its latest Bottom Brook Rare Earth Elements project analysis.

Optimi Health makes first international MDMA shipment

Optimi Health (CSE:OPTI) makes its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University.

Oncolytics Biotech approved to expand pancreatic cancer program

Oncolytics Biotech (TSX:ONC), a cancer immunotherapy stock, receives ethics and German regulatory approvals for a new pancreatic cancer study.